What we really want to do is flatten our glucose curves without increasing the amount of insulin in the body
In other words, BPC 157 isnt just for athletes or post-op patients its a versatile peptide with wide-reaching healing potential from the inside out
GLP-1 medications solve this by using modified versions of the hormone that resist enzymatic breakdown, maintaining elevated levels for days or even a full week depending on the formulation
doi: 10.3389/fphar.2026.1768006 Received 15 December 2025 Revised 01 February 2026 Accepted 10 February 2026 Published 25 February 2026 Volume 17 - 2026 Edited by Jianxiang Zhang, Army Medical University, China Reviewed by Fatemeh Saheb Sharif-Askari, University of Sharjah, United Arab Emirates Xiaojing Hou, Nanjing Women and Childrens Healthcare Hospital, China Updates Copyright 2026 Binmahfouz
After 104 weeks of treatment, the primary outcome of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke occurred in 6.6% of the patients in the semaglutide group and 8.9% of those in the placebo group, resulting in a hazard ratio (HR) of 0.74 (95% CI 0.580.95) [13]
These methods are ideal for those who prefer to avoid surgery and medications
